SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Forgent Power Solutions, Inc. is a holding company, which engages in the design and manufacture of electrical distribution equipment used in data centers, power grid, and energy-intensive industrial facilities. It also offers powertrain solutions and standard and custom products. The company was founded on July 21, 2025 and is headquartered in Dayton, MN.

Forgent Power Solutions Inc. - Ordinary Shares - Class A

Forgent Power Solutions Inc.

Forgent Power Solutions is receiving attention following a robust earnings report that highlighted triple-digit revenue growth and significant backlog expansion, driving optimism about its role in the AI data center infrastructure market. While some investors are concerned by volatility and recent share offerings, the community reaction remains overwhelmingly bullish, with many viewing pullbacks as buying opportunities for a long-term electrification play.

SPDR S&P 500 ETF TRUST - SPDR S&P 500 ETF Trust

The index is trending lower as market participants weigh rising bond yields and oil prices alongside increasing concerns regarding the pace of AI development and safety. Traders are heavily focused on the upcoming Federal Reserve policy meeting, with high expectations for a rate hike contributing to broader market uncertainty and bearish sentiment.

Rolls-Royce Holdings Plc designs, develops, manufactures, and services integrated power systems for use in the air, on land, and at sea. The company operates its business through following segments: Civil Aerospace, Power Systems, and Defense. The Civil Aerospace segment offers commercial aero engines and aftermarket services. The Power Systems segment includes engines, power systems and nuclear systems for civil power generation. The Defense segment consists of military aero engines, naval engines, submarines and aftermarket services. The company was founded in March 1906 and is headquartered in London, the United Kingdom.

Rolls-Royce Holdings Plc - ADR

Rolls-Royce is trending as investors anticipate upcoming half-year earnings and updates on potential major hyperscaler data center contracts. The conversation is driven by the company's strong performance across its Civil Aerospace, Defence, and Power Systems divisions, alongside ongoing community enthusiasm for its small modular reactor (SMR) development.

iShares Trust - iShares 20+ Year Treasury Bond ETF

iShares 20+ Year Treasury Bond ETF

Investors are actively debating the Federal Reserve's next policy move as rising Treasury yields and persistent inflation keep upward pressure on interest rates. The community is focused on the impact of these macro headwinds, with many traders expressing bearish sentiment toward bond prices as market expectations for a rate hike grow.

Amazon.com, Inc. is a multinational technology company, which engages in the provision of online retail shopping services. It operates through the following segments: North America, International, and Amazon Web Services (AWS). The North America segment offers retail sale of consumer products, including from sellers, advertising, and subscriptions services through North America-focused online and physical stores. The International segment focuses on retail sale of consumer products, including sellers, advertising, and subscription services through internationally focused online stores. The AWS segment is composed of global sales of computers, storage, databases, and other services for start-ups, enterprises, government agencies, and academic institutions. The company was founded by Jeffrey P. Bezos in July 1994 and is headquartered in Seattle, WA.

Amazon.com Inc.

Amazon.com Inc

Amazon is garnering attention following a multi-year partnership with Qualcomm to develop custom AI chips and infrastructure for AWS data centers. While some traders express frustration over recent stock performance and unrelated external incidents, others highlight the firm's expanding AI and cloud ecosystem as a long-term catalyst.

Zoracles

Zoracles is experiencing increased community attention and volatility as traders debate the potential for a short squeeze driven by high future contract positions relative to its market cap. While some investors remain bullish on long-term growth and utility, others express frustration over extended price stagnation and characterize the project as a speculative pump and dump.

Intel Corp. engages in the design, manufacture, and sale of computer products and technologies. It delivers computer, networking, data storage, and communications platforms. The firm operates through the following segments: Client Computing Group (CCG), Data Center and AI (DCAI), Intel Foundry Services (IFS), and All Other. The CCG segment consists of platforms designed for notebooks, 2-in-1 systems, desktops, tablets, phones, wireless and wired connectivity products, and mobile communication components. The DCAI segment delivers solutions to cloud service providers and enterprise customers, along with silicon devices for communications service providers and high-performance computing customers. The IFS segment refers to full stack solutions created from the foundry industry ecosystem. The All Other segment represents results from other non-reportable segments and corporate-related charges. The company was founded by Robert Norton Noyce and Gordon Earle Moore on July 18, 1968, and is headquartered in Santa Clara, CA.

Intel Corp.

Intel Corp

Intel is trending as traders debate the impact of broader industry volatility, including recent calls from AI executives to slow the development of frontier models. While some investors fear this signals a potential cooling of AI infrastructure demand, many maintain a bullish outlook, pointing to Intel's strategic foundry buildout and long-term data center growth prospects.

Nasdaq, Inc. is a holding company, which engages in trading, clearing, exchange technology, regulatory, securities listing, information, and public and private company services. It operates through the following segments: Capital Access Platforms, Financial Technology, and Market Services. The Capital Access Platforms segment delivers liquidity, transparency, and integrity to the corporate issuer and investment community by empowering clients to effectively navigate the capital markets, achieve their sustainability goals, and drive governance excellence. The Financial Technology segment offers platforms that improve the liquidity, transparency, and integrity of the global economy by architecting and operating the markets. The Market Services segment includes equity derivative trading and clearing, cash equity trading, fixed income, currency, and commodities trading. The company was founded by Gordon S. Macklin in 1971 and is headquartered in New York, NY.

Nasdaq Inc - Ordinary Shares - 144A

Nasdaq Inc

The community is focused on Nasdaq's strategic initiative to implement 23-hour trading, which has sparked debate regarding increased liquidity versus potential overnight volatility. Traders are also monitoring the impact of regulatory updates and ongoing index inclusion activity on the exchange's market structure.

AeroVironment, Inc. is a defense technology company delivering integrated capabilities across air, land, sea, space, and cyber. The company develops and deploys autonomous systems, loitering munitions, counter-UAS technologies, space-based platforms, directed energy systems, and cyber and electronic warfare capabilities-built to meet the mission needs of today’s warfighter and tomorrow’s conflicts. At the core of these technologies lies AV_Halo, a modular, mission-ready suite of AI-powered software tools that empowers warfighters and enables full-battlefield dominance: detect, decide, deliver. With a national manufacturing footprint and a deep innovation pipeline, AV delivers proven systems and future-defining capabilities at speed, scale, and operational relevance. The company was founded by Paul B. MacCready, Jr. in July 1971 and is headquartered in Arlington, VA.

AeroVironment Inc.

AeroVironment shares are receiving significant attention following the announcement of a multi-million dollar contract for its directed-energy counter-drone laser systems. Traders are debating whether this development and the company's strong, record-breaking backlog will catalyze a price recovery, with many expressing frustration over the stock's recent downward performance despite positive fundamental news.

Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care and Rare Disease segments. The Diabetes and Obesity Care segment includes diabetes, obesity, cardiovascular, and emerging therapy areas. The Rare Disease segment refers to rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company was founded by Harald Pedersen and Thorvald Pedersen in 1923 is headquartered in Bagsværd, Denmark.

Novo Nordisk - ADR

Novo Nordisk A/S

Novo Nordisk is trending as traders debate the company's long-term growth prospects following a downgrade by Deutsche Bank and persistent concerns over competition from Eli Lilly. While some investors view the recent price decline as an opportunity to accumulate shares at an undervalued level, others are concerned about patent cliffs and the stock's recent performance.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Whitehawk Therapeutics Presents Real-World Analyses Supporting PTK7 as a Durable ADC Target in EGFR Wild-Type Non-Small Cell Lung Cancer at WCLC 2026

Whitehawk Therapeutics Presents Real-World Analyses Supporting PTK7 as a Durable ADC Target in EGFR Wild-Type Non-Small Cell Lung Cancer at WCLC 2026 Whitehawk Therapeutics Presents Real-World Analyses Supporting PTK7 as a Durable ADC Target in EGFR Wild-Type Non-Small Cell Lung Cancer at WCLC...

Whitehawk Therapeutics Appoints Vijay Iyengar, MD, to Board of Directors

Whitehawk Therapeutics Appoints Vijay Iyengar, MD, to Board of Directors Whitehawk Therapeutics Appoints Vijay Iyengar, MD, to Board of Directors PR Newswire MORRISTOWN, N.J., Sept. 10, 2026 Former Incyte Executive Brings Extensive Oncology, Corporate Strategy, Business Development and Medical...

Whitehawk Therapeutics to Participate in Upcoming Investor Conferences

Whitehawk Therapeutics to Participate in Upcoming Investor Conferences Whitehawk Therapeutics to Participate in Upcoming Investor Conferences PR Newswire MORRISTOWN, N.J., Sept. 2, 2026 MORRISTOWN, N.J., Sept. 2, 2026 /PRNewswire/ -- Whitehawk Therapeutics, Inc.(Nasdaq: WHWK), a clinical-stage...

What Makes Whitehawk Therapeutics, Inc. (WHWK) a Strong Momentum Stock: Buy Now?

Does Whitehawk Therapeutics, Inc. (WHWK) have what it takes to be a top stock pick for momentum investors? Let's find out.

Wall Street Analysts Predict a 47.64% Upside in Whitehawk Therapeutics, Inc. (WHWK): Here's  What You Should Know

The mean of analysts' price targets for Whitehawk Therapeutics, Inc. (WHWK) points to a 47.6% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.

Whitehawk Therapeutics Reports Second Quarter 2026 Financial Results and Recent Highlights

Whitehawk Therapeutics Reports Second Quarter 2026 Financial Results and Recent Highlights Whitehawk Therapeutics Reports Second Quarter 2026 Financial Results and Recent Highlights PR Newswire MORRISTOWN, N.J., Aug. 6, 2026 Phase 1 trials for HWK-007 and HWK-016 continue to enroll; the Phase 1...

Biocytogen and Whitehawk Therapeutics Enter Global Collaboration for Bispecific Antibody ADC Development

Biocytogen (SSE: 688796; HKEX: 02315) and Whitehawk Therapeutics, Inc. (Whitehawk, Nasdaq: WHWK) today announced a global collaboration to develop bispecific antibody-drug conjugates (BsADC). Biocytogen will provide access to up to five bispecific antibodies using its proprietary RenLite platform...

Whitehawk Therapeutics Presents RealWorld Analysis Confirming SEZ6 as a Highly Expressed, Clinically Relevant Target for SCLC and Other Neuroendocrine Tumors at ASCO 2026

Whitehawk Therapeutics Presents RealWorld Analysis Confirming SEZ6 as a Highly Expressed, Clinically Relevant Target for SCLC and Other Neuroendocrine Tumors at ASCO 2026 Whitehawk Therapeutics Presents RealWorld Analysis Confirming SEZ6 as a Highly Expressed, Clinically Relevant Target for SCLC...

Whitehawk Therapeutics to Present at the Jefferies 2026 Global Healthcare Conference

Whitehawk Therapeutics to Present at the Jefferies 2026 Global Healthcare Conference Whitehawk Therapeutics to Present at the Jefferies 2026 Global Healthcare Conference PR Newswire MORRISTOWN, N.J., May 28, 2026 MORRISTOWN, N.J., May 28, 2026 /PRNewswire/ -- Whitehawk Therapeutics, Inc.(Nasdaq...

WHWK Stock Edges Up After Hours: Firm Boosts Pipeline Of Cancer Drugs On The Heels Of Capital Raise  

Equity

Whitehawk said it has secured rights from Hangzhou DAC to use the CPT113 linker-payload technology in up to five additional internally developed programs.

Whitehawk Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company. It develops precision therapies for genetically-defined cancer patients with mTOR pathway driver alterations such as alterations in TSC1 or TSC2 genes. The company was founded by Neil Desai in November 2007 and is headquartered in Morristown, NJ.

Whitehawk Therapeutics Inc.

Bullish Sentiment

50bps hike

25bps hike

No change

25bps cut

The Federal Reserve's September FOMC meeting concludes Wednesday, September 16, with a rate decision due at 2:00 PM ET, following Tuesday's CPI report that showed inflation still running above the Fed's 2% target. What do you think the Fed decides at this week's FOMC meeting? Vote and explain your reasoning in the comments.

The Fed&#39;s rate decision comes Wednesday at 2PM ET. What do you think happens?

Stocktwits

The Fed's rate decision comes Wednesday at 2PM ET. What do you think happens?

Feed

News

Sentiment

Earnings

Fundamentals

Info

WHWK Whitehawk Therapeutics Inc.

Fundamentals

Latest WHWK News